Stockscreener 앱 받기
0.84
2.10%
-0.018
시간 외 거래:
.86
0.02
+2.38%
전일 마감가:
$0.858
열려 있는:
$0.84
하루 거래량:
45,522
Relative Volume:
0.19
시가총액:
$13.27M
수익:
-
순이익/손실:
$-19.54M
주가수익비율:
-0.6426
EPS:
-1.3071
순현금흐름:
$-21.18M
1주 성능:
-9.82%
1개월 성능:
+27.83%
6개월 성능:
-83.27%
1년 성능:
-50.30%
1일 변동 폭
$0.84
$0.8924
1주일 범위
$0.8059
$0.9701
52주 변동 폭
$0.4606
$7.20
Calcimedica Inc Stock (CALC) Company Profile
명칭
Calcimedica Inc
전화
858-952-5500
주소
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.84 | 13.74M | 0 | -19.54M | -21.18M | -1.3071 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc 주식(CALC)의 최신 뉴스
CalciMedica (CALC) Slips 2.75% as Stock Tests Key Support LevelsVolatility Breakout Picks - newsline.com
CALC Q1 2026 Earnings: Surprising Profitability Amid No RevenueHigh Growth Earnings - newsline.com
CALC Stock Chart | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
CALC Q1 2026 Earnings: Surprise Profit Amid Pre-Revenue Pipeline ProgressEPS Consistency Score - newsline.com
CalciMedica (CALC) Slips 6%: Support Level Holds Key to RecoveryCTA Positioning - newsline.com
CalciMedica (CALC) Faces Selling Pressure Near Support as Biotech Uncertainty PersistsInitial Balance - newsline.com
CALC Q1 2026 Earnings: Surprising Profit on a Per‑Share Basis, Yet Shares DeclineOne-Time Loss Impact - thelegaladvocate.com
CalciMedica (CALC) Edges Lower, Approaching Critical Support at $0.70PCR Mean Reversion - The Legal Advocate
CalciMedica (CALC) Holds Near Support as Price Movement Remains MinimalTotal Put Call - newsline.com
Number of shareholders of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CALC Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Clinical-Stage InvestmentsRevenue Guidance Update - The Legal Advocate
CalciMedica (CALC) Rises +4.47%: Technicals vs Fundamentals — Which Wins? 2026-05-21Trading Community - Newser
CalciMedica (CALC) reporting person holds 0 shares after amendment - Stock Titan
CalciMedica, Inc. (CALC) Fundamental Analysis - Meyka
Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC) - The Globe and Mail
CalciMedica (CALC) Q4 2025 Disappoints — EPS $-0.73 Below $-0.42 ViewsInvestment Community - Newser
Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA) - The Globe and Mail
[10-Q] CalciMedica, Inc. Quarterly Earnings Report - Stock Titan
CalciMedica Releases Q1 2026 Financial Results - AlphaStreet
CalciMedica Reports Q1 2026 Financial Results, Advances Auxora and CM5480 Clinical Programs - Minichart
TradingKey - TradingKey
CalciMedica posts Q1 profit on higher other income, lower expenses - TradingView
CalciMedica (NASDAQ: CALC) swings to Q1 profit as expenses decline - Stock Titan
CalciMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - PR Newswire
[SCHEDULE 13G/A] CalciMedica, Inc. Amended Passive Investment Disclosure - Stock Titan
CalciMedica Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
CalciMedica (CALC) details 2025 executive pay, ownership and $20.4M raise - Stock Titan
CALC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is CalciMedica (CALC) stock a long-term winner | Q4 2025: Earnings UnderperformMarket Expert Watchlist - Newser
CalciMedica (CALC) Stock: Sentiment Analysis | Q4 2025: Below ExpectationsSector Outperform - Xã Châu Thành
CALC Options Chain — NASDAQ:CALC - TradingView
MACD Signal: Does CalciMedica Inc outperform in volatile marketsMarket Sentiment Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Profit Review: Does CalciMedica Inc have consistent dividend growth2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
EPS Watch: Is CalciMedica Inc attractive for institutional investorsPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Jobs Data: Is CalciMedica Inc exposed to currency risks2026 PostEarnings & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
CalciMedica (NASDAQ: CALC) grants CSO 65,124 options at $0.585 - Stock Titan
CalciMedica (CALC) CFO receives 67,728 stock options at $0.585 strike price - Stock Titan
CalciMedica (CALC) grants 65,124 stock options to President and COO - Stock Titan
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteriaMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
CALC PE Ratio & Valuation, Is CALC Overvalued - Intellectia AI
CALC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CalciMedica (CALC) price target decreased by 24.39% to 10.54 - MSN
If You Invested $1,000 in CALCIMEDICA INC (CALC) - Stock Titan
Revenue Check: Does CalciMedica Inc meet Warren Buffetts criteria2026 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Big Picture: Does CalciMedica Inc meet Warren Buffetts criteriaShare Buyback & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CalciMedica receives Nasdaq delisting notices for market value and bid price - Investing.com Australia
CalciMedica Receives Nasdaq Deficiency Notices on Listing Standards - TipRanks
CalciMedica Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Calcimedica Inc (CALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Calcimedica Inc 주식 (CALC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 15 '25 |
Buy |
2.68 |
3,400 |
9,105 |
81,650 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 12 '25 |
Buy |
3.12 |
5,000 |
15,600 |
78,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 09 '25 |
Buy |
3.15 |
2,343 |
7,378 |
73,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 28 '25 |
Buy |
2.86 |
9,200 |
26,340 |
70,107 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 29 '25 |
Buy |
2.74 |
800 |
2,192 |
70,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 21 '25 |
Buy |
2.79 |
3,508 |
9,797 |
60,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 20 '25 |
Option Exercise |
1.53 |
15,000 |
22,950 |
179,706 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 20 '25 |
Buy |
2.72 |
2,000 |
5,440 |
57,399 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 19 '25 |
Buy |
2.79 |
1,000 |
2,790 |
55,399 |
| Hebbar Sudarshan | Chief Medical Officer |
Aug 19 '25 |
Buy |
2.82 |
9,563 |
26,962 |
61,539 |
2.60%
0.94%
자본화:
|
볼륨(24시간):